Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd LBLTF

Healthcare Medical Devices
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


GREY:LBLTF - Post by User

Lattice Biologics Ltd > Core vs. COVID19
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
Comment by Nomoreshells4meon Jul 16, 2020 8:23am
102 Views
Post# 31274755

RE:RE:RE:RE:Core vs. COVID19

RE:RE:RE:RE:Core vs. COVID19
Medicago uses cannabinoids. Looks interesting. Another to check out is Axim. Big move yesterday and more to come. Yah , Guy's words haven't matched his actions. March 17th, May 11th and the Alumina press release. All mentioned COVID-19 at least 7 times. I'm pretty sure he was targeting the attention being put on the pandemic and investors looking to play biotech companies involved in a solution. Montana has gone from 50 to 1,000 cases in June and they don't seem to be able to get a 10 patients study completed. God help them in the 300 patient study. I'm sure the dentists are happy though. Lol
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities